Terlipressin for Injection-Esophageal Variceal Bleeding

Background:

Terlipressin for Injection is a pharmacological agent that has found widespread use in the medical field, particularly in the management of various conditions related to circulatory and hepatic disorders. This medication is a synthetic analogue of vasopressin, a hormone that plays a crucial role in regulating blood flow and fluid balance in the body. Terlipressin's unique properties make it a valuable tool in addressing specific medical conditions, and its administration via injection allows for rapid and controlled delivery.

The primary mechanism of action of terlipressin involves its interaction with vasopressin receptors in blood vessels. Vasopressin, also known as antidiuretic hormone, normally functions to constrict blood vessels and reduce urine production, thereby increasing blood pressure. Terlipressin mimics this action, leading to vasoconstriction and an elevation in blood pressure. This effect is particularly beneficial in situations where increased blood flow is essential, such as in the management of certain circulatory disorders.

One key use of terlipressin is in the management of variceal bleeding, a severe complication often associated with liver cirrhosis. The medication's vasoconstrictive effects are employed to reduce blood flow in dilated blood vessels (varices) in the esophagus or stomach, thereby decreasing the risk of bleeding and promoting Hemostasis. Terlipressin is often integrated into the treatment protocols for acute variceal bleeding, demonstrating its role in preventing life-threatening complications.

We provide Terlipressin For Sale for a long time, including Terlipressin For Esophageal Variceal Bleeding and Terlipressin Lyophilized Powder and so on.

The administration of Terlipressin for Injection requires careful consideration of patient-specific factors, including the underlying medical condition, renal function, and overall hemodynamic status. While generally considered safe, the medication may be associated with adverse effects such as gastrointestinal disturbances, bradycardia, or peripheral ischemia. Monitoring and dose adjustments are essential to optimize therapeutic benefits while minimizing potential risks.

Hemostatic Products - Terlipressin for Injection:

The recommended starting dose of this product is 2mg, slowly intravenous injection (more than 1 minute), while monitoring blood pressure and heart rate. The maintenance dose is 1~2mg intravenously every 4~6 hours until the bleeding is controlled, and the treatment time is 24~48 hours.

It is recommended that the maximum daily dose is 120~150μg/kg. If bleeding is not controlled, other treatments should be considered.